1. Home
  2. KMDA vs FFIC Comparison

KMDA vs FFIC Comparison

Compare KMDA & FFIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • FFIC
  • Stock Information
  • Founded
  • KMDA 1990
  • FFIC 1929
  • Country
  • KMDA Israel
  • FFIC United States
  • Employees
  • KMDA N/A
  • FFIC N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • FFIC Major Banks
  • Sector
  • KMDA Health Care
  • FFIC Finance
  • Exchange
  • KMDA Nasdaq
  • FFIC Nasdaq
  • Market Cap
  • KMDA 443.4M
  • FFIC 401.3M
  • IPO Year
  • KMDA N/A
  • FFIC 1995
  • Fundamental
  • Price
  • KMDA $7.72
  • FFIC $12.34
  • Analyst Decision
  • KMDA Strong Buy
  • FFIC Hold
  • Analyst Count
  • KMDA 2
  • FFIC 3
  • Target Price
  • KMDA $13.00
  • FFIC $16.17
  • AVG Volume (30 Days)
  • KMDA 55.4K
  • FFIC 301.7K
  • Earning Date
  • KMDA 08-13-2025
  • FFIC 07-24-2025
  • Dividend Yield
  • KMDA 2.59%
  • FFIC 7.13%
  • EPS Growth
  • KMDA 31.21
  • FFIC N/A
  • EPS
  • KMDA 0.28
  • FFIC N/A
  • Revenue
  • KMDA $167,235,000.00
  • FFIC $137,137,000.00
  • Revenue This Year
  • KMDA $14.51
  • FFIC $110.74
  • Revenue Next Year
  • KMDA $9.31
  • FFIC $7.28
  • P/E Ratio
  • KMDA $28.31
  • FFIC N/A
  • Revenue Growth
  • KMDA 11.83
  • FFIC N/A
  • 52 Week Low
  • KMDA $5.08
  • FFIC $10.65
  • 52 Week High
  • KMDA $9.16
  • FFIC $18.59
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 53.97
  • FFIC 51.11
  • Support Level
  • KMDA $7.64
  • FFIC $11.84
  • Resistance Level
  • KMDA $7.91
  • FFIC $12.74
  • Average True Range (ATR)
  • KMDA 0.18
  • FFIC 0.34
  • MACD
  • KMDA -0.02
  • FFIC -0.01
  • Stochastic Oscillator
  • KMDA 50.00
  • FFIC 49.50

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About FFIC Flushing Financial Corporation

Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.

Share on Social Networks: